Carey Thomas D.
SEC CIK 1574633 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC. | Dir | 344.5K | — | — | 6 | 2024-01-05 | 2026-06-18 |
Most active insiders at LAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Casdin Partners GP, LLC | Dir, 10% | $11.41M | — |
| 2 | Casdin Eli | Dir, 10% | $1.37M | — |
| 3 | Casdin Partners Master Fund, L.P. | Dir, 10% | $1.12M | — |
| 4 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | $503.0K | — |
| 5 | Kim Hanjoon Alex | CFO | — | — |
| 6 | Mackay Sean | SVP, Chief Business Off | — | — |
| 7 | Cox Troy | Dir | — | — |
| 8 | Carey Thomas D. | Dir | — | — |
| 9 | Egholm Michael | Pres, CEO, Dir | — | — |
| 10 | Witney Frank | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:45 | 2026-06-18 | LAB | STANDARD BIOTOOLS INC. | Carey Thomas D. | Dir | A - Grant | $0.00 | +99.1K | 344.5K | +40% | $0 |
| 2026-03-02 | 2026-02-26 | LAB | STANDARD BIOTOOLS INC. | Carey Thomas D. | Dir | A - Grant | $1.17 | +51.3K | 245.3K | +26% | +$60.0K | |
| D | 2025-06-24 | 2025-06-20 | LAB | STANDARD BIOTOOLS INC. | Carey Thomas D. | Dir | A - Grant | $0.00 | +94.6K | 194.1K | +95% | $0 |
| 2025-03-04 | 2025-02-28 | LAB | STANDARD BIOTOOLS INC. | Carey Thomas D. | Dir | A - Grant | $1.07 | +56.3K | 99.5K | +131% | +$60.3K | |
| D | 2024-07-02 | 2024-06-28 | LAB | STANDARD BIOTOOLS INC. | Carey Thomas D. | Dir | A - Grant | $0.00 | +43.1K | 43.1K | New | $0 |
| D | 2024-01-09 | 2024-01-05 | LAB | STANDARD BIOTOOLS INC. | Carey Thomas D. | Dir | A - Grant | $0.00 | +79.4K | 79.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations